The Monterrey Institute of Technology and Higher Education (ITESM) and the Massachusetts Institute of Technology (MIT) signed a collaboration agreement to promote research and development in nanoscience and nanotechnology in Mexico.
The event held last Friday was attended by Salvador Alva, ITESM President; Jose Antonio Fernandez, President of the ITSEM’s Administrative Council; Eduardo Medina Mora, Mexico’s ambassador in the United States; and Daniel Hernandez Joseph, Mexico’s Consul General in Boston.
The agreement, unique in Latin America, provides a scenario for increasing long-term collaboration between the two universities. To do this, it was established an academic program, which will enable students and teachers of the Monterrey institution to do internships and research stays in the laboratories of MIT.
Participants in the program will gain experience researching on topics that match their own interests. The program will be able to change or expand its focus until within 5 years. According to Jesus del Alamo, program coordinator at MIT, “This initiative will develop a broad intellectual front.”
Currently, MIT is building MIT.nano facility, which will be essential for the program’s future extensions. The building will have an area of 200,000 square feet and located at the heart of the MIT campus. MIT.nano will house state-of-the-art cleanroom, imaging, and prototyping facilities supporting research with nanoscale materials and processes — in fields including energy, health, life sciences, quantum sciences, electronics, and manufacturing.
In honor of the new relationship, the facility’s Computer-Aided Visualization Environment will be named after Tecnológico de Monterrey (ITSEM), says Vladimir Bulović, the Fariborz Maseeh Chair in Emerging Technology and faculty lead for the MIT.nano building project.
The program will begin in spring 2015 and the first exchanges will be carried out during next year’s summer.
ITESM’s Research projects have focused primarily on biotechnology, developing preventive and therapeutic strategies to care for diseases like cancer and diabetes, as well as projects related to nutrigenomics, bioprocessing, renewable energy and green technologies.
Through: MIT, Milenio